Corrigendum to “Elevated circulating AIF1L as a cell-free RNA biomarker of preeclampsia impairs trophoblast function via mitochondrial dysregulation” [Translational Research 296 (2026) 198–212]
Corrigendum to “Elevated circulating AIF1L as a cell-free RNA biomarker of preeclampsia impairs trophoblast function via mitochondrial dysregulation” [Translational Research 296 (2026) 198–212]. // Translational Research. – URL: https://www.sciencedirect.com/science/article/pii/S193152442600188X?dgcid=rss_sd_all
Corrigendum to “Elevated circulating AIF1L as a cell-free RNA biomarker of preeclampsia impairs trophoblast function via mitochondrial dysregulation” [Translational Research 296 (2026) 198–212]. Translational Research. https://www.sciencedirect.com/science/article/pii/S193152442600188X?dgcid=rss_sd_all
“Corrigendum to “Elevated circulating AIF1L as a cell-free RNA biomarker of preeclampsia impairs trophoblast function via mitochondrial dysregulation” [Translational Research 296 (2026) 198–212].” Translational Research.
@article{article70102,
title = {Corrigendum to “Elevated circulating AIF1L as a cell-free RNA biomarker of preeclampsia impairs trophoblast function via mitochondrial dysregulation” [Translational Research 296 (2026) 198–212]},
journal = {Translational Research},
url = {https://www.sciencedirect.com/science/article/pii/S193152442600188X?dgcid=rss_sd_all}
}
ABSTRACT Three‐dimensional (3D) printing enables precise control over scaffold geometry, porosity, material distribution, and spatial delivery of cells and bioactive cues. However, features intended to improve biological fidelity often...